Concepedia
Statistics
Publications
6
Citations
322
H-Index
Active since
2009
Affiliations
University of Novi Sad(Current)
Gilead Sciences (United States)
Thomas Jefferson University
Masaryk University
Medical University of Warsaw
Milotka Fabri is an author at University of Novi Sad specializing in viral hepatitis, pharmacotherapy, and viral hepatitis treatment.
Publications per year
2009–2016
Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B
Scott Fung, Peter Kwan, Milotka Fabri et al. · Gastroenterology · 2013 · 148 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +14
The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference
Angelos Hatzakis, Pierre Van Damme, Keith Alcorn et al. · Journal of Viral Hepatitis · 2013 · 75 citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +14
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study
Scott Fung, Peter Kwan, Milotka Fabri et al. · Journal of Hepatology · 2016 · 61 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +13
Leptospirosis distribution related to freshwater habitats in the Vojvodina region (Republic of Serbia)
Zorica Svirčev, Slobodan B. Marković, J Vukadinov et al. · Science in China Series C Life Sciences · 2009 · 17 citations
Veterinary Medicine, Ecology, Infectious Diseases +11
744 TENOFOVIR DF (TDF) IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH PRE-EXISTING MILD RENAL IMPAIRMENT
S. Fung, Peter Kwan, Andrzej Horban et al. · Journal of Hepatology · 2013 · 11 citations
Pharmacy, Pharmacokinetics, Pharmacotherapy +11
1–5 of 6